Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6169776 | The Breast | 2015 | 4 Pages |
Abstract
The Z0011 trial and the AMAROS trial demonstrated a similar phenomenon for axillary treatment; less surgery does not necessarily lead to inferior local control or survival outcomes. Recent studies supplement the growing evidence that treatment of patients with MF/MC breast cancer with BCS, radiotherapy, and adjuvant systemic therapy can result in low rates of in-breast recurrence.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Matthijs V. Nijenhuis, Emiel J.Th. Rutgers,